「ca」の検索結果
159件：41～45件目を表示
-
千寿製薬株式会社
hthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V member 1 Inhibition（PDF） September 4, 2025 Senju has developed and obtain...
http://www.senju.co.jp/english/ -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
We contribute to society through the cause of the idea to serve the health of people since our formation, through providing the pharmaceutical products. As better corporate citizens, we promote the en...
http://www.senju.co.jp/english/about/csr.html -
CEO Message | About Senju | SENJU Pharmaceutical
ent medicines and services focusing on the ophthalmology field through our unique ideas and R&D capabilities.Throughout our history, we have cultivated a sense of values that we call “SENJU SENSE”...
http://www.senju.co.jp/english/about/message.html -
Business Activities | About Senju | SENJU Pharmaceutical
y that puts top priority on safety, we have always taken a pioneering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to tak...
http://www.senju.co.jp/english/about/business/ -
Quality Policies | About Senju | SENJU Pharmaceutical
ways pay close attention to the quality of our products to provide customers with better pharmaceuticals and comply with laws and standards with high ethical standards on product quality, and exercise...
http://www.senju.co.jp/english/about/quality.html